changing from semaglutide to mounjaro Switching Wegovy: How it Works Switching from Ozempic to Mounjaro
Description
The STEP-NASH trial demonstrated improvement in NASH resolution and fibrosis

As more individuals are diagnosed with these conditions, the need for glucagon-like peptide 1 (GLP-1) analogue therapies continues to grow

Understanding your genetic predispositions helps explain whether your rebound risk is low, moderate, or high

In conclusion, the complete history of GLP-1 drugs from gut hormone discovery to blockbuster therapy exemplifies the ideal arc of translational medicine

Int J Obes 49 , 402411 (2025)
